The Latest Breaking News from FDA

Friday Plans has a stellar 4.3-star rating on Trustpilot, with 40,000+ subscribers praising the convenience, speed, affordability, and effectiveness of their Viagra and Cialis products.

Experts explain what the expected FDA ban on formaldehyde in hair-straightening products really means for everyday Americans.

A deadline for the White House to review a proposal to ban the extra-addictive cigarettes expired last month with no action

The recall was initiated on March 9, 2024, and is ongoing, per an official notice from the FDA

The biotechnology industry is expected to grow rapidly due to rising demand for personalized medicines, increased R&D spending, and the adoption of AI in the biopharma market. Hence, quality biotech stocks Incyte (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) could be poised for breakthroughs this month. Read more….

The pharmaceutical industry is experiencing rapid growth thanks to healthcare demand, regulatory initiatives, and technological adoption in drug discovery and development. Hence, it could be wise to invest in pharma stocks Ipsen (IPSEY), Bristol-Myers (BMY), and Taro Pharmaceutical (TARO) to drive your bottom line. These stocks are rated A (Strong…

The pharma industry’s resilience and long-term prospects are driven by rising healthcare demand, an enhanced focus on precision medicines, and technological advancements. Hence, let’s take a look at pharma stocks Perrigo Company (PRGO), Amneal Pharmaceuticals (AMRX), and Supernus Pharmaceuticals (SUPN), which could diversify your investments. Read on….

Florida is on track to ban cell-cultivated meat while three others float it – but experts say the reasoning has little to do with safety, ethical or environmental questions

The illnesses were reported in two people who received fake Botox or a similar, possibly counterfeit products in LaSalle County, health officials said.

Natco Pharma's Kothur facility near Hyderabad receives FDA warning letter over quality concerns, impacting product approvals.

The research the FDA relies upon to claim banning menthol cigarettes would improve public health is not aligned with the agency's approach to tobacco regulation.